Research Support

Funding Opportunities

Title Description Expires Sort ascending Grant Number
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)

The purpose of this funding opportunity announcement (FOA) is to support clinical studies that will fill gaps in the design of upcoming clinical trials in rare neurological or neuromuscular diseases by validating clinical outcome measures or biomarkers, or by characterizing cohorts of relevant patients. This is the reissue of PAR 18-534 and has replaced PAR 18-534.

Expiration February 17, 2022

PAR-19-220
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to publicize a competition for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These Centers promote collaborative basic, translational, and clinical research and provide important resources that can be used by the national muscular dystrophy research communities. The Centers also provide outstanding environments for the training of new researchers capable of addressing high priority research objectives in the muscular dystrophies. Center investigators are expected to participate in important community outreach efforts to increase awareness of their research activities in the patient and advocacy communities and to incorporate community perspectives into the conduct of patient-centered research.

RFA-AR-21-008

Information for Researchers

Funding Opportunities for Muscular Dystrophy Research

FY20 Duchenne Muscular Dystrophy Research Program (DMDRP)

Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers

CureDuchenne Ventures 2020 Pitch Contest Submission Deadline: July 13, 2020!

Muscular Dystrophy Research Support from MDCC Member Organizations

2018 Supported Projects
2017 Supported Projects
2016 Supported Projects
2015 Supported Projects